Skip to main content
Signal8

Avoro Capital Advisors LLC

SEC insider (Form 3/4/5 filer). CIK 0001633313. Director & 10% Owner at Whitehawk Therapeutics, Inc. (WHWK). 1 reported Form 4/5 transaction since Sep 2024; latest on May 12, 2026. Located in NEW YORK, NY.

Companies Avoro Capital Advisors LLC has filed insider reports for

  • Whitehawk Therapeutics, Inc. (WHWK): Director, 10% Owner
Avoro Capital Advisors LLC profile photo

Avoro Capital Advisors LLC

CIK: 0001633313

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Whitehawk Therapeutics, Inc. logo
WHWK

Whitehawk Therapeutics, Inc.

Director10% Owner

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • Whitehawk Therapeutics, Inc. logo
    WHWK

    Whitehawk Therapeutics, Inc.

    May 12, 2026
    Award

    Pre-funded Warrant (right to buy)

    Indirect
    6.4M shares at avg. $3.92-

1-1 of 1